KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Healthpeak Properties (DOC) EBIT (2016 - 2026)

Healthpeak Properties has reported EBIT over the past 17 years, most recently at $205.8 million for Q4 2025.

  • Quarterly EBIT fell 84.68% to $205.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.0 billion through Dec 2025, down 1336.13% year-over-year, with the annual reading at $589.5 million for FY2025, 7.04% up from the prior year.
  • EBIT was $205.8 million for Q4 2025 at Healthpeak Properties, up from -$239.3 million in the prior quarter.
  • Over five years, EBIT peaked at $1.3 billion in Q4 2024 and troughed at -$779.0 million in Q2 2025.
  • The 5-year median for EBIT is -$192.3 million (2021), against an average of -$207.2 million.
  • Year-over-year, EBIT crashed 266.76% in 2023 and then soared 329.89% in 2024.
  • A 5-year view of EBIT shows it stood at -$175.1 million in 2021, then dropped by 19.63% to -$209.5 million in 2022, then plummeted by 178.91% to -$584.3 million in 2023, then skyrocketed by 329.89% to $1.3 billion in 2024, then plummeted by 84.68% to $205.8 million in 2025.
  • Per Business Quant, the three most recent readings for DOC's EBIT are $205.8 million (Q4 2025), -$239.3 million (Q3 2025), and -$779.0 million (Q2 2025).